Αρχειοθήκη ιστολογίου

Τετάρτη 23 Μαΐου 2018

Mogamilizumab Prior to Allogeneic Hematopoietic Stem Cell Transplantation

This case series describes characteristics of 8 patients with mycosis fungoides or Sézary syndrome who received mogamulizumab before allogeneic hematopoietic stem cell transplantation and any resulting graft-vs-host disease–related complications.

https://ift.tt/2GIcSV3

Δεν υπάρχουν σχόλια:

Δημοσίευση σχολίου